C.FarmerA
(PubMed) Hemila H
This strategy suits users who plateau after several months suggesting diminishing returns, want to minimize long-term costs while maintaining some benefits, prefer avoiding indefinite commitments to any treatment, notice maintained improvements during initial breaks suggesting cycling viability, and value flexibility over maximum continuous optimization
IGF-1 LR3 is not appropriate for patients who are pregnant or breastfeeding, have active cancer or a cancer history (because IGF-1 stimulates cell growth broadly, including potentially malignant cells), have uncontrolled diabetes or diabetic retinopathy, or are under 21
The medications listed above are some of the options available through the LifeMD Comprehensive Weight Management Program
Dive deeper Energy treatments backed by a Stanford PhD-led team With our fully in-house Medical, Research, and Customer Care teams, every protocol is vetted for safety, efficacy, and being on the forefront of longevity science